SCHEMBL4498501

SCHEMBL4498501

Oc1ccc(Nc2ncccn2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 8/20 0.63
SYK P43405 2/20 0.51
PLK1 P53350 5/20 0.50
ACHE P22303 1/20 0.50
MEN1 O00255 2/20 0.49
MAPT P10636 2/20 0.49
KMT2A Q03164 2/20 0.49
NPC1 O15118 1/20 0.49
TYR P14679 1/20 0.49
NFKB1 P19838 1/20 0.49
RAB9A P51151 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
GAA P10253 1/20 0.48
HTT P42858 1/20 0.48
RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6532650 0.80 AURKA (0.52) AURKASYKPLK1MEN1MAPT
SCHEMBL15968669 0.78 AURKA (0.63) AURKASYKMEN1MAPTKMT2A
SCHEMBL911 0.78 AURKA (0.63) AURKASYKMEN1MAPTKMT2A
SCHEMBL5959433 0.78 AURKA (0.59) AURKASYKMEN1MAPTKMT2A
SCHEMBL1321961 0.78 AURKA (1.00) AURKASYKPLK1MEN1MAPT
SCHEMBL28762614 0.78 SYK (0.67) SYKPLK1MEN1KMT2AMAPK8
SCHEMBL1120968 0.77 AURKA (0.42) AURKAPLK1MEN1MAPTKMT2A
SCHEMBL4500527 0.77 AURKA (0.42) AURKAPLK1ACHEMEN1MAPT
SCHEMBL1120994 0.77 PIK3CG (0.51) AURKASYKPLK1ACHEMEN1
SCHEMBL4583809 0.77 RAD52 (0.56) AURKASYKPLK1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-85103378-A Process for preparing a group of novel compounds, formulations containing these compounds and their use in therapy 1986-07-09 CN claimed
EP-0013143-A2 Substituted anilinopyrimidines, compositions and use thereof as herbicides, processes for their preparation and intermediates for use therein ICI AUSTRALIA LIMITED (AU) 1980-07-09 EP claimed
US-20240245699-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SERVIER LAB (FR) 2024-07-25 US disclosed
US-20210290631-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2021-09-23 US disclosed
US-11058689-B2 Pyrrole compounds, a process for their preparation and pharmaceutical LES LABORATOIRES SERVIER (FR) 2021-07-13 US disclosed
US-20200261464-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2020-08-20 US disclosed
US-10688101-B2 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATORIES SERVIER (FR) 2020-06-23 US disclosed
US-10662173-B2 Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2020-05-26 US disclosed
US-10414754-B2 Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2019-09-17 US disclosed
US-20190192528-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2019-06-27 US disclosed
US-10265323-B2 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2019-04-23 US disclosed
CN-100577160-C Novel azabicyclo derivatives, preparation method thereof and pharmaceutical compositions containing same SERVIER LAB 2010-01-06 CN disclosed
US-7576120-B2 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2009-08-18 US disclosed
CN-101230033-A New azabicycloalkane derivatives, preparing method and medicament combination containing the same SERVIER LAB (FR) 2008-07-30 CN disclosed
EP-1720544-B1 NOVEL AZABICYCLIC DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SERVIER LAB (FR) 2008-03-19 EP disclosed
US-20070197625-A1 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. LES LABORATORATIES SERVIER (FR) 2007-08-23 US disclosed
CN-1921848-A Novel azabicyclo derivatives, preparation method thereof and pharmaceutical compositions containing same SERVIER LAB (FR) 2007-02-28 CN disclosed
EP-1720544-A1 NOVEL AZABICYCLIC DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME Les Laboratoires Servier (FR) 2006-11-15 EP disclosed
WO-2005089747-A1 NOVEL AZABICYCLIC DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2005-09-29 WO disclosed
CN-85103378-A Process for preparing a group of novel compounds, formulations containing these compounds and their use in therapy 1986-07-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662173-B2 Indole and pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them RB1, IDO1, BCL2A1 AURKA 1599/4885SYK 2573/4885PLK1 812/4885
US-11058689-B2 Pyrrole compounds, a process for their preparation and pharmaceutical PDCD11, RRM2B, RRS1 AURKA 2680/4885SYK 1444/4885PLK1 1822/4885
US-20210290631-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PDCD11, RRM2, RRM2B AURKA 2539/4885SYK 1701/4885PLK1 1291/4885
US-20200261464-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PDCD11, RRS1, RRM2B AURKA 2771/4885SYK 1463/4885PLK1 1746/4885
US-10414754-B2 Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them IDO1, API5, IDO2 AURKA 1422/4885SYK 580/4885PLK1 2599/4885
US-20070197625-A1 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. HRH2, HNMT, HRH1 AURKA 1367/4885SYK 622/4885PLK1 4603/4885
US-20240245699-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PDCD11, RRM2B, RRM2 AURKA 2696/4885SYK 1497/4885PLK1 1626/4885
US-10688101-B2 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them PDCD11, RRM2B, RRM2 AURKA 2696/4885SYK 1497/4885PLK1 1626/4885
US-20190192528-A1 PYRROLE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PDCD11, RRM2B, RRM2 AURKA 2696/4885SYK 1497/4885PLK1 1626/4885
US-10265323-B2 Pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them PDCD11, RRM2B, RRM2 AURKA 2696/4885SYK 1497/4885PLK1 1626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.